Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a U.S. healthcare system: The STEP trial.
复制标题
DOI:
10.1016/j.cct.2022.106960
复制
发表时间:
2022-11
影响因子:
2.2
通讯作者:
Buist, Diana S. M.
中科院分区:
文献类型:
--
作者:
Winer, Rachel L.;Lin, John;Anderson, Melissa L.;Tiro, Jasmin A.;Meenan, Richard T.;Hansen, Kristina;Gao, Hongyuan;Sparks, Angela;Greene, Dina N.;Kilgore-Martin, Sony;Green, Beverly B.;Buist, Diana S. M.
Mailing HPV self-sampling kits to overdue individuals increases cervical cancer screening adherence; offering self-sampling to previously adherent individuals has not been evaluated in the U.S. Given heterogeneity of the U.S. health system and population, data are needed to optimize how HPV self-sampling is offered to individuals who are overdue, due after successful past screening, or have an unknown screening history. STEP is a pragmatic randomized controlled trial set within a U.S. integrated healthcare delivery system, designed to compare different outreach approaches for offering HPV self-sampling in populations defined by prior screening behavior (previously-adherent, overdue, or unknown screening history). Over 14 months, eligible individuals were identified through electronic medical record (EMR) data and randomized to Usual Care (UC), Education (UC + educational materials about cervical cancer screening), Direct-Mail (UC + Education + a mailed self-sampling kit) or Opt-In (UC + Education + option to request a kit), depending on screening history. The primary objective is to compare screening completion by outreach approach and screening history. Secondary objectives include evaluating incremental cost-effectiveness of outreach approaches, and identifying patient preference for, and satisfaction with, HPV self-screening, and barriers to abnormal results follow-up (measured through interviews and focus groups). The trial was designed to generate data that U.S. health systems can use to inform primary HPV screening implementation strategies that incorporate HPV self-sampling options to improve screening access, adherence, and patient satisfaction. The objective of this report is to describe the rationale and design of this pragmatic trial.
登录
查看更多内容
影响因子:
9.7
作者:
Bates, David W.;Bitton, Asaf
通讯作者:
Bitton, Asaf
影响因子:
12.7
作者:
JANERICH, DT;HADJIMICHAEL, O;POLEDNAK, AP
通讯作者:
POLEDNAK, AP
影响因子:
10.3
作者:
Leyden, WA;Manos, MM;Taplin, SH
通讯作者:
Taplin, SH
影响因子:
4.7
作者:
Kinney, W;Sung, HY;Hiatt, RA
通讯作者:
Hiatt, RA
影响因子:
8.8
作者:
Leinonen, Maarit K.;Schee, Kristina;Nygard, Mari
通讯作者:
Nygard, Mari